Statement Of Cash Flows [Abstract]

Redcare Pharmacy N.V. - Filing #1858571

Concept	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	As at 2019-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Income taxes paid (refund), classified as operating activities	—	179,000 EUR	—	329,000 EUR	—
Cash flows from (used in) operating activities	—	11,635,000 EUR	—	17,802,000 EUR	—
Cash flows from (used in) investing activities [abstract]
Cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities	—	31,181,000 EUR	—	0 EUR	—
Purchase of property, plant and equipment, classified as investing activities	—	13,818,000 EUR	—	38,235,000 EUR	—
Purchase of intangible assets, classified as investing activities	—	29,341,000 EUR	—	15,100,000 EUR	—
Interest received, classified as investing activities	—	31,000 EUR	—	93,000 EUR	—
Cash flows from (used in) investing activities	—	84,297,000 EUR	—	40,164,000 EUR	—
Cash flows from (used in) financing activities [abstract]
Proceeds from issuing shares	—	0 EUR	—	63,381,000 EUR	—
Proceeds from borrowings, classified as financing activities	—	13,000,000 EUR	—	0 EUR	—
Repayments of borrowings, classified as financing activities	—	5,663,000 EUR	—	37,000 EUR	—
Payments of lease liabilities, classified as financing activities	—	5,784,000 EUR	—	2,362,000 EUR	—
Cash flows from (used in) financing activities	—	229,590,000 EUR	—	50,193,000 EUR	—
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes	—	156,928,000 EUR	—	27,831,000 EUR	—
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents	—	0 EUR	—	0 EUR	—
Cash and cash equivalents	247,413,000 EUR	—	90,485,000 EUR	—	62,653,000 EUR